Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients.

× No keyword cloud information.

21 in total

1. Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia.

Authors: Yue Zhou; Li Wang; Xiao-Ying Zhai; Li Wen; Fang Tang; Fan Yang; Xi-Ting Liu; Lei Dong; Li-Juan Zhi; Hai-Yan Shi; Guo-Xiang Hao; Yi Zheng; Evelyne Jacqz-Aigrain; Tian-You Wang; Wei Zhao
Journal: Br J Clin Pharmacol Date: 2020-03-03 Impact factor: 4.335

Review 2. Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.

Authors: Rochelle R Maxwell; Peter D Cole
Journal: Curr Hematol Malig Rep Date: 2017-06 Impact factor: 3.952

Review 3. Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia.

Authors: Tiphaine Adam de Beaumais; Evelyne Jacqz-Aigrain
Journal: Eur J Clin Pharmacol Date: 2012-03-16 Impact factor: 2.953

4. Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.

Authors: Y Tanaka; A Manabe; H Fukushima; R Suzuki; H Nakadate; K Kondoh; K Nakamura; K Koh; T Fukushima; M Tsuchida; K Koike; N Kiyokawa; E Noguchi; R Sumazaki; T Komiyama
Journal: Pharmacogenomics J Date: 2014-11-18 Impact factor: 3.550

Review 5. Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.

Authors: Volker M Lauschke; Lili Milani; Magnus Ingelman-Sundberg
Journal: AAPS J Date: 2017-11-27 Impact factor: 4.009

6. Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A.

Authors: Pooja Budhiraja; Mordecai Popovtzer
Journal: Nat Rev Nephrol Date: 2011-06-28 Impact factor: 28.314

7. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.

Authors: Lin Yang; Xin Hu; Luhang Xu
Journal: Tumour Biol Date: 2012-04-20

8. Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers.

Authors: E W Chua; S Cree; M L Barclay; K Doudney; K Lehnert; A Aitchison; M A Kennedy
Journal: Pharmacogenomics J Date: 2015-03-10 Impact factor: 3.550

Review 9. [Research advances in pharmacogenomics of mercaptopurine].

Authors: Xiao-Xiao Chen; Shu-Hong Shen
Journal: Zhongguo Dang Dai Er Ke Za Zhi Date: 2017-09

10. Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.

Authors: Guillermo Gervasini; Jose M Vagace
Journal: Front Genet Date: 2012-11-22 Impact factor: 4.599